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Abstract
Aims In the UK, lifestyle intervention is first-line management in Type 2 diabetes. It is unclear what type of diet is most
efficacious for improving glycaemic control. This study investigated the effects of an oat-enriched diet on glycaemic
control, postprandial glycaemia, inflammation and oxidative stress compared with standard dietary advice.
Methods In a randomized crossover design, 27 volunteers with Type 2 diabetes, managed on diet and lifestyle only,
were observed for two consecutive 8-week periods following either the oat-enriched diet or re-enforced standard dietary
advice. Volunteers attended at baseline (habitual intake) and 8 and 16 weeks. Measurements included basic clinical
measurements and fasted and postprandial (3-h) glucose and insulin in response to a healthy test meal. Markers of
inflammation and oxidative stress, including high-sensitivity C-reactive protein, interleukin 6, interleukin 18, tumour
necrosis factor-alpha, adiponectin, thiobarbituric acid reactive substances, oxygen radical antioxidant capacity, oxidized
LDL and urinary isoprostanes, were also measured at fasting and in the postprandial period.
Results There were no diet-related effects on glycaemic control or glycaemic or insulinaemic responses to the test meal.
Total cholesterol (5.1  1.0 vs. 4.9  0.8 mmol/l, P = 0.019) concentrations declined following the oat-enriched diet
compared with standard dietary advice. There was a postprandial decline in adiponectin concentration (P = 0.009), but
no effect of dietary intervention. None of the measures of oxidative stress or inflammation were altered by the oat-
enriched diet compared with standard dietary advice.
Conclusion The oat-enriched diet had a modest impact on lipid lowering, but did not impact on oxidative stress or
inflammation in these volunteers with Type 2 diabetes.
Diabet. Med. 30, 1314–1323 (2013)
Introduction
Lifestyle intervention is the first line of management in
Type 2 diabetes [1]. National Institute for Health and
Clinical Excellence (NICE) [1] guidelines recommend that
people with diabetes should follow principles of healthy
eating. It is unclear what type of diet is most efficacious for
long-term glycaemic control, independent of weight loss. A
recent Cochrane review [2] concluded that low glycaemic
index diets can potentially lower HbA1c by approximately
5 mmol/mol (0.5%). Nonetheless, many studies considered
within this review used a high glycaemic index diet as the
control [3], itself likely to have adverse effects on glycaemic
control. Improvement between moderate and low glycaemic
index diets is less certain.
Postprandial hyperglycaemia may be a risk factor for
cardiovascular disease. In the Diabetes Epidemiology: Col-
laborative analysis of Diagnostic criteria in Europe
(DECODE) study, 2-h plasma glucose following an oral
glucose tolerance test was an independent predictor for
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cardiovascular disease and mortality [4]. Postprandial
hyperglycaemia may result in enhanced oxidative stress
contributing to cardiovascular risk. Human umbilical vein
endothelial cells exposed to variable glucose concentrations
show an increase in production of harmful reactive oxygen
species [5]. Importantly, in volunteers with Type 2 diabetes
there was a direct correlation between postprandial glyca-
emia and plasma nitrotyrosine concentrations [6], while
urinary excretion of 8-iso prostaglandin F2a (a marker of
oxidative stress) correlated with acute glucose fluctuations,
but not with fasting plasma glucose or HbA1c [7]. Further-
more, control of postprandial hyperglycaemia with repagli-
nide resulted in regression of carotid intima thickness and
reductions in markers of systemic inflammation [8].
Many oat products have a low glycaemic index [9] and
offer an easily identified source of carbohydrate that could
contribute to a lowered overall dietary glycaemic index.
Indeed, individuals with Type 2 diabetes have favourable
plasma glucose and insulin profiles after oats or oat bran
meals [10]. Oat-based diets may also have other health
benefits, notably on lipid profiles [11] and levels of oxidative
stress, inflammation and antioxidant capacity [12].
The hypothesis examined here was that an oat-enriched
diet modulates postprandial hyperglycaemia and may be
associated with beneficial effects on fasting and postprandial
concentrations of markers of oxidative stress and inflamma-
tion.
Volunteers
Men and post-menopausal women with Type 2 diabetes
managed by diet and lifestyle alone (n = 27) were recruited
from two Scottish Health Boards (Aberdeen and Inverness)
(Table 1). Inclusion criteria included: HBA1c < 64 mmol/mol
(8%) and age 40–75 years. Exclusion criteria were a history
of significant liver, renal or cardiovascular disease or certain
medications (including corticosteroids, hormone replacement
therapy, anticoagulants, aspirin and statins).
Volunteers underwent medical screening and provided
written informed consent. The North of Scotland Research
Ethics Service approved the study, which complied with the
Declaration of Helsinki and its amendments.
Methods
This randomized, crossover design study involved dietary
intervention with both re-enforced conventional standard
dietary advice and a modified diet, based on consumption of
additional oat products, each for 8 weeks with no washout
between. Volunteers were also tested at the start of the study
(week 0), at which point they were following their habitual
diet. Participants for each order of diet intervention were
matched (in order) by sex, age, BMI and, where needed,
HbA1c, with allocation to either group by independent
statistical supervision. In consequence, the two groups did
not differ in any of these variables. The study was conducted
between July 2008 and December 2010.
Standard dietary advice
Standard dietary advice for Type 2 diabetes is based on
healthy eating recommendations. Prior to the standard
dietary advice phase of the trial, volunteers received a
re-inforced message on dietary advice. This was supple-
mented by literature regarding dietary and lifestyle advice
[13]. Volunteers were also instructed to avoid oats whilst
following the standard dietary advice intervention.
Oat-enriched diet
When following the oat-enriched diet, individuals were
given a range of selected commercially available oat-based
products (including cereals, oatcakes, bread, cereal bars)
readily available commercially (see Table 2). Products were
chosen on the basis of oat content, and those with lower
saturated fat and refined sugar contents were preferentially
selected. Oat bread containing 30% oats was developed by
Macphie of Glenbervie Ltd (Glenbervie, Stonehaven, UK)
and produced by J. G. Ross (Bakers) Ltd (Highclere
What’s new?
• No differences were observed in measurements of
glycaemic control following either chronic intervention
with the oat-enriched diet or acutely following an oat-
enriched meal.
• A small beneficial effect of oats on plasma lipid profiles
was observed that may have implications for reducing
cardiovascular risk profiles.
• Consumption of a relatively healthy test meal produced
smaller inflammatory responses than reported using
either artificially high fat or carbohydrate loads.
• Results reinforce the importance of adhering to healthy
eating advice in Type 2 diabetes in terms of reducing
systemic levels of inflammation and oxidative stress and
therefore cardiovascular risk.
Table 1 Baseline characteristics of subjects (n = 27)
Men:women 18:9
BMI (kg/m2) 31.5  0.98 (23.5–42.4)
HbA1c (mmol/mol) 50.5  1.44 (35.5–66.1)
HbA1c (%) 6.8  0.14 (5.4–8.2)
Age (years) 60.9  1.23 (46–71)
Duration of diabetes (months) 37.0  8.3 (3-180)
Values given are means  SEM (range).
ª 2013 The Authors.
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Business Park, Inverurie, UK). Volunteers were provided
with written guidelines on how they might include oat
products in their diet. They were asked to substitute part of
the carbohydrate content at each meal with an oat-based
product, to include 60–100 g of oats per day and to record
the amount of oats consumed at each meal in a study diary
based on a ‘points’ system where 1 ‘point’ equalled 10 g of
oats, as determined by the manufacture’s nutritional
information (see Table 2).
Otherwise, diabetes care and management of the patients
was not altered. Volunteers continued to be monitored by
their own medical practitioner, who had the right to advise
withdrawal from the study at any time if control of diabetes
proved unsatisfactory; this did not occur.
Clinical and glycaemic measurements
At weeks 0 (baseline), 8 and 16, volunteers attended at
08.00 h after an overnight fast of at least 10 h. The
following measurements were undertaken:
Fasting measurements
1. Weight; height (plus BMI calculation); waist circumfer-
ence; blood pressure.
2. Fasting lipid profile (total cholesterol, LDL, HDL and
triglycerides).
3. Fasting plasma glucose and insulin concentrations in
triplicate plasma samples taken 5 min apart. Glucose
was determined in duplicate using a Konelab 30 selective
chemistry analyser (Thermo Electron Corporation,
Basingstoke, UK) using a standard glucose (HK) assay
kit (Thermo 981304) and insulin concentrations were
determined in duplicate using a solid two-site enzyme
immunoassay [enzyme linked immunosorbent assay
(ELISA), Mercodia insulin (Mercodia Inc., Uppsala, Swe-
den)]. Intra-assay coefficient of variation was 4.6% and
interassay coefficient of variation was 3.6%.
4. Insulin resistance and b-cell function were calculated by
homeostasis model assessment of insulin resistance
(HOMA-IR) and b-cell function (HOMA-B), respectively
[14].
5. HbA1c was measured using a liquid chromatography
method and Diabetes Control and Complications Trial
(DCCT)-aligned laboratory equipment.
6. The following inflammatory markers were measured:
6.1. plasma C-reactive protein (CRP) using a quantitative
sandwich enzyme immunoassay technique (Quantikine
Human CRP Immunoassay; R&D Systems Europe Ltd,
Abingdon, UK). Intra-assay coefficient of variation was
4.1% and interassay coefficient of variation was 6.5%;
6.2. plasma adiponectin using a quantitative sandwich
enzyme immunoassay technique (Quantikine Human
Adiponectin Immunoassay; R&D Systems Europe Ltd)
Intra-assay coefficient of variation was 3.4% and
interassay coefficient of variation was 6.5%;
6.3. plasma interleukin (IL)-6, IL-18 and tumour necrosis
factor alpha (TNF-a) by ELISA approaches (eBioscience
Ltd, Hatfield, UK); with the interassay coefficient of
variation of 5.2, 8.1 and 8.1% and intra-assay coeffi-
cient of variation of 3.4, 6.5 and 7.7%, respectively.
7. The following measures of antioxidant capacity and
oxidative stress were assessed in plasma:
7.1. oxygen radical antioxidant capacity (ORAC) based on
oxidation of a fluorescent probe by peroxyl radicals
through hydrogen atom transfer (Cell Biolabs Inc., San
Diego, CA, USA) (intra-assay coefficient of variation
6.2%);
7.2. malondialdehyde (MDA), a by-product of lipid perox-
idation, assessed spectrophotometrically after extraction
with n-butanol from plasma collected in EDTA tubes
(OxiSelect TBARS Assay Kit; Cell Biolabs Inc.) (intra-
assay coefficient of variation 6.0%);
7.3. fasting oxidized LDL quantified using ELISA kit
(Mercodia Inc.). Intra-assay coefficient of variation
was 4.5%, interassay coefficient of variation was 6.9%;
7.4. urinary isoprostane was measured using a competitive
enzyme-linked assay for 8-iso-prostaglandin F2a (Oxi-
Select; Cell Biolabs Inc.) and creatinine was measured at
the Raigmore Hospital clinical biochemistry laboratory
(Inverness, UK).
Test meal
Initial fasting blood samples were taken via a cannula placed
in an antecubital fossa vein. Subjects then consumed a test
meal that contained 3.3 MJ metabolizable energy (approx-
imately 30% of daily energy intake), with a calculated
glycaemic load of 56 g and a glycaemic index of 57%. Meal
composition followed that recommended by the UK Depart-
ment of Health [15] as healthy eating and contained 100 g
carbohydrate (approximate glycaemic index 57%; 51%
metabolizable energy from carbohydrate, 14% metaboliz-
able energy from protein and 32% metabolizable energy
from fat). The test meal did not contain wholegrain or oat-
based products. Subjects were instructed to consume the test
meal within 15 min and blood samples were withdrawn
immediately before ingestion and then at 15-min intervals for
3 h. Both incremental and total areas under the curve (AUCi
and AUCt) were determined by trapezoid procedures. Insulin
secretion in response to glycaemic stimulus was calculated as
the incremental area under the curve(insulin)/ incremental
area under the curve(glucose).
Continuous glucose monitoring system and food diaries
On the morning of the test meal, volunteers were fitted with a
continuous glucose monitoring system (Medtronic Ltd,
Watford, UK) to assess glucose excursions in the free-living
ª 2013 The Authors.
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state. Volunteers also completed food diaries over this period
and were provided with digital electronic scales with a tare
facility; they recorded food and drink consumed, time of
consumption, weight of food and drink, cooking method and
leftovers. The volunteers were instructed to record all recipes
and to keep packaging for ready-to-eat food products. When
scale use was difficult, volunteers provided information
regarding type and quantity of food eaten, using household
measures. Diets were analysed using WinDiets Nutritional
Analysis Software Suite (version 1.0; The Robert Gordon
University, Aberdeen, UK), a computerized version of
McCance and Widdowson: The Composition of Foods
[16]. Standard portion sizes were used to input foods with
household measures or with missing weights or portion sizes
[17]. Total energy and nutrient intake for each meal were
quantified. The glycaemic index of the different foodstuffs
was taken from published reference tables [9]. Dietary
glycaemic index was calculated as the sum of the glycaemic
index value of each foodstuff multiplied by available
carbohydrate content (total carbohydrate minus dietary
fibre) expressed as a proportion of the total available
carbohydrate for the day. Dietary glycaemic load was
calculated as the sum of the product of the glycaemic index
for each foodstuff and its available carbohydrate content,
divided by 100.
Experimental power
The study power was based on a number of primary
measurements within the volunteer (notably incremental or
total areas under the curve for both glycaemia and insulina-
emia, plus the inflammatory marker IL-6). For all these, and
assuming a within-volunteer spread of 20% or less (observed
for aforementioned outcomes in previous studies with similar
volunteers, either in-house or from the existing literature),
n = 30 was needed to detect treatment differences of 15%
with 80% power at 5% significance (based on paired t-test).
Statistics
Data were analysed by random effects models using the
restricted maximum likelihood (REML) estimation in Gen-
stat 13th edition, release 13.2 (VSN International, Hemel
Hempstead, UK). For postprandial time course data, the
random effects consisted of volunteer, with week (0, 8 or
16 week) and time (time points following the test meal), plus
their interaction, nested within volunteer. Fixed effects were
site, gender, diet, time and week, with all interactions
between diet, time and week considered, but for site and
gender interactions these were restricted to those with diet
and week. For outcomes consisting of one observation per
diet (such as the overnight fasting sample or incremental area
under the curve), time was removed from the analyses. Data
for standard dietary advice vs. oat-enriched diet treatments
were also analysed with baseline measures as covariate.
Following inspection of the residual plots, data based on
CRP and the ratio of isoprostane:creatinine were analysed
after log10 transformation in order to stabilize the variance.
For these variables, the mean data (and 95% confidence
intervals) presented in Table 4 represent back-transformed
values from the statistical output. For Figs 1–3, data are
presented as mean and SEM, while in Tables 3–6 the standard
error of the difference (SED) for diet comparisons from the
restricted maximum likelihood analysis is given. Where
significant responses (P < 0.05) were observed for main
effects or interactions, then post-hoc t-tests (no correction for
multiple comparisons) were applied to determine differences
between mean values. P < 0.05 was regarded as significant.
Results
The food diaries did not reveal any differences in total
energy intake or macronutrient composition, including
FIGURE 1 Glycaemic response to standard test meal at baseline and
following dietary intervention. Values are means. Habitual (pre-
intervention) ( ); standard dietary advice ( ); oat-enriched diet
( ). Effect of time, P < 0.001. Effect of diet, P = 0.036. Interaction
between postprandial time 9 diet, P < 0.001.
FIGURE 2 Insulinaemic response to standard test meal at baseline and
following dietary intervention. Values are means. Habitual (pre-
intervention) ( ); standard dietary advice ( ); oat-enriched diet
( ). Effect of postprandial time, P < 0.001. Effect of diet, P = 0.967.
Interaction between postprandial time 9 diet, P = 0.774.
1318
ª 2013 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
DIABETICMedicine The effect of oats on glycaemia, inflammation and oxidative stress  S. C. McGeoch et al.
available carbohydrate content, during the three different
diet phases (habitual diet, standard dietary advice or oat-
enriched diet). During the oat-enriched diet, both oat and
portions of wholegrains (as defined by the US Department
of Health [18]) consumed increased markedly (P < 0.001),
with mean oat intake in excess of 100 g/day (range 42.2–
233.2 g/day). This was ~3 and ~10 times the intake under
habitual diet and standard dietary advice, respectively.
There was no difference in dietary glycaemic load (109–
125 g/day) or glycaemic index (50–52%) across the three
dietary phases (Table 3).
Dietary interventions had no effect on fasting plasma
values or anthropometric and clinical measurements
(Table 4). Although there was no overall effect of diet on
total cholesterol, values declined by 0.2 mmol/l (P = 0.019,
by post-hoc t-test) on the oat-enriched diet compared with
standard dietary advice when baseline values were applied as
a covariate. The outcomes did not show any effect of period
(P for week > 0.05), nor were any crossover effects observed
(P for interaction between diet and week > 0.05).
There were no effects of time in the study (week) for any of
the measurements.
There were no significant effects (P < 0.05) for measure-
ments of glycaemic control (postprandial hyperglycaemia)
derived from the continuous glucose monitoring system
between the habitual diet and after 8 weeks on either
standard dietary advice or the oat-enriched diet (data not
shown).
In response to the test meal, both incremental and total
areas under the curve for glucose increased (by 19 and 14%,
respectively; P < 0.05) for both the oat-enriched diet and
standard dietary adivice compared with the habitual diet
(Table 5, Fig. 1). In contrast, there were no effects of diet on
insulin responses to the test meal (Table 5, Fig. 2), nor in the
index of insulin response to glucose.
For nine volunteers, IL-18 concentrations were below the
limit of assay detection (9 pg/ml), but for those subjects with
detectable IL-18 at baseline (n = 18), both fasted and
postprandial values were higher (P = 0.001) following
standard dietary advice than either the habitual or oat-
enriched diet. There was no effect of diet on fasting or
postprandial concentrations of other markers of inflamma-
tion or oxidative stress (Table 6). However, there was a
postprandial decline (P = 0.009) in adiponectin concentra-
tions following the standard test meal. This was not affected
by chronic diet (Fig. 3).
Discussion
The current study demonstrated that a palatable oat-
enriched dietary regimen can be developed using readily
available products. Judging by weighed food diary data,
compliance with the oat-based diet was excellent. Further-
more, oat consumption exceeded the minimum target
required for this study (60 g/day). A major strength of the
current study is that volunteers followed both test diets at
home and so the results represent what can be realistically
achieved in the free-living state. The volunteers with Type 2
diabetes were already well controlled by diet alone and the
control arm of the study was based on the standard dietary
advice offered conventionally. This contrasts with other
studies where often dietary extremes are compared [3]. The
findings of previous studies would not therefore necessarily
reflect improvements that might be achieved over and above
following standard dietary advice. Furthermore, the stan-
dard test meal used to assess postprandial glycaemic,
insulinaemic and inflammatory responses was deliberately
designed to represent that which such patients are encour-
aged to eat. Other researchers have used more extreme and
less healthy options [19–21]. The current study therefore
has, in both design and execution, examined responses from
an initial baseline of recommended healthy eating and, as
such, will most likely address marginal improvements, but in
a clinically relevant context.
Weaknesses of the current study include the small number
of volunteers, but many published studies involve similar
numbers. Furthermore, power calculations suggest that the
total number of volunteers (n = 27) should be sufficient to
detect realistic changes (15%) in certain key markers
measured. While this study does not achieve the strict dietary
control found with a residential programme, it is realistic in
terms of free-living lifestyles. Recruitment to nutritional
studies is subject to bias as more motivated and health-
conscious individuals are likely to volunteer.
Clinical measurements
The current data support previous reports that an
oat-enriched diet reduces plasma concentrations of total
cholesterol. For example, supplementation with 6 g/day
FIGURE 3 Adiponectin concentrations following the standard test meal
at baseline and following dietary intervention. Values are means.
Habitual (pre-intervention) ( ); standard dietary advice ( ); oat-
enriched diet ( ). Effect of time, P = 0.009. Effect of diet, P = 0.452.
Interaction between postprandial time 9 diet, P = 0.582.
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oat-derived b-glucan lowered total cholesterol (from 5.9 to
4.9 mmol/l, 17%) [11]. Porridge oats contain approximately
3.6 g of b-glucan per 100 g, therefore an intake of 6 g/day
b-glucan, would require a daily intake of 170 g of oats. This
compares with the 109 g/day (range 42.2–233.2 g/day)
achieved in the current study, equivalent to daily intakes of
b-glucan of 3.9 g (range 1.5–8.4 g/day). This smaller amount
of daily b-glucan produced a more modest decrease, albeit
from a lower baseline (initial total cholesterol 5.0 mmol/l).
The greater reductions previously reported [11] may be
attributable to weight loss, whereas the current subjects
maintained weight. This is important because it has been
shown that weight loss is an effective strategy to reduce
lipaemia [22].
Low glycaemic index diets can improve glycaemic control
[2] and a low glycaemic index diet reduces postprandial
glycaemic excursions and 24-h area under the curve for
glucose, as measured by the continuous glucose monitoring
system [23]. Many oat products have a reasonably low
glycaemic index [9] and regular consumption of these
products would help lower the overall diet glycaemic index,
with potential improvement in glycaemic control. In the
current study, the glycaemic index of the habitual diet was
already low at 51. The similarity of diet glycaemic index for
the habitual and oat-enriched diets means that substitution of
other carbohydrates by the oat products did not lower either
the glycaemic index or glycaemic load and this may explain
the lack of response in measurements of glycaemic control.
Table 3 Daily total energy and macronutrient intake for both groups
Baseline n = 24 Standard diet n = 24 Oat diet n = 24 sed P
Energy (kJ) 8716 8384 8749 407.2 0.615
Energy (kcal) 2085 2006 2093 97.4 0.615
Fat% of energy 31.92 32.91 33.17 1.458 0.666
Fat (kJ) 2891 2810 2936 217 0.842
Protein% of energy 19.35*† 21.11* 17.96
†
1.326 0.068
Protein (kJ) 1696 1685 1541 92.3 0.184
Carbohydrate% of energy 47.37 44.87 48.12 1.926 0.222
Carbohydrate (kJ) 4024 3801 4203 248.8 0.279
Saturated fat% of energy 11.24 10.37 10.77 0.732 0.499
Saturated fat (kJ) 1025 886 943 85.7 0.273
Salt (g) 8.2 7.75 7.5 0.928 0.745
Total sugars (g) 93.6* 76.9† 80.4*† 6.83 0.045
Dietary fibre (g) 25.83 25.43 23.88 2.39 0.691
Portions of fruit and vegetables 5.2* 4.7*† 3.52† 0.617 0.027
Portions of wholegrain foodstuffs 4.03* 2.79† 6.55‡ 0.559 < 0.001
Oats (g) 29.1* 10.9† 109.2‡ 8.11 < 0.001
Available carbohydrate (g) 221.4 209.6 237.7 12.9 0.148
Glycaemic load 114.2 108.6 124.5 6.6 0.124
Glycaemic index 50.9 50.6 52.0 1.54 0.799
Values are means. Values within a row with different symbols (*, †, ‡) are different (P < 0.05).
Table 4 Values for fasting plasma values, anthropometric and clinical measurements during the study; n = 27
Habitual diet Standard dietary advice Oat-enriched diet sed P
BMI (kg/m2) 31.5*† 31.4* 31.7† 0.14 0.015
Weight (kg) 90.1*† 89.8* 90.4† 0.42 0.030
Systolic blood pressure (mmHg) 130.3 133.0 137.1 3.58 0.221
Diastolic blood pressure (mmHg) 75.4 76.0 77.0 2.17 0.828
Pulse (beats min–1) 65.3 65.6 65.9 2.71 0.917
HbA1c (mmol/mol) 50.5 52.8 51.9 1.23 0.12
HbA1c (%) 6.8 7.0 6.9 0.10 0.124
Total cholesterol (mmol/l) 5.0* 5.1*† 4.9*‡ 0.09 0.111
LDL (mmol/l) 3.1 3.2 3.0 0.09 0.162
HDL (mmol/l) 1.2 1.3 1.2 0.03 0.370
Triglycerides (mmol/l) 1.38 1.51 1.54 0.08 0.131
Fasting plasma glucose (mmol/l) 7.7 8.3 8.0 0.26 0.108
Fasting plasma insulin (mU/l) 11.0 11.0 10.6 0.77 0.810
HOMA-IR (mU/mmol/l) 3.9 4.2 4.0 0.34 0.799
HOMA-B (mU/mmol) 52.4 51.4 47.1 3.60 0.315
Oxidized LDL (U/l) 60.0 61.3 59.0 1.70 0.396
Values are means. Values within the same row with different symbols (*, †, ‡) are different (P < 0.05). P-values compare data across all three
dietary phases.
HOMA-B, homeostasis model assessment of b-cell function; HOMA-IR, homeostasis model assessment of insulin resistance.
1320
ª 2013 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
DIABETICMedicine The effect of oats on glycaemia, inflammation and oxidative stress  S. C. McGeoch et al.
Although the addition of cereal fibre to the diet can
improve the glycaemic response to a standard test meal in
volunteers with Type 2 diabetes [24], this was not observed
in the current study, despite the substantial quantity of oats
and wholegrains consumed. This may be in part because of
the lack of increase in dietary fibre content, Overall,
adoption by the subjects of an improved diet following
diagnosis of Type 2 diabetes may have blunted the potential
of the oat-enriched diet to increase dietary fibre and exert
beneficial effects on glycaemic responses.
Inflammation and oxidative stress
Chronic ingestion of the oat-enriched diet had no effect on
fasting concentrations for the markers of oxidative stress
and inflammation measured. Previous data suggest that
following a low glycaemic index diet for 1 year can reduce
CRP [25], although a 6-week intervention with a diet rich in
whole grains did not [26]. Fasting CRP concentrations are
sensitive to weight loss and exercise [27] and the unchanged
body weight and exercise habits in the current study may
explain why inflammatory marker concentrations were
unaltered.
Arnalich et al. [28] suggested that improved glycaemic
control results in decreased thiobarbituric acid reactive
substance concentrations, while Botero et al. [29] showed
increases in oxygen radical antioxidant capacity concentra-
tions in volunteers with Type 2 diabetes following a low,
compared with a high, glycaemic index diet. Furthermore,
Rector et al. [30] demonstrated reduced oxidized LDL after
lifestyle intervention involving weight loss and aerobic
exercise. Again, in the current study the absence of reduced
diet glycaemic index, stable body weight and unaltered
exercise habits [as assessed by the International Physical
Activity Questionnaire (IPAQ) (data not shown)] may
account for the lack of effect.
A number of studies have demonstrated a rise in markers of
inflammation and oxidative stress in the postprandial period
[6,21,31], although whether this is linked to postprandial
hyperglycaemia [19] or triglyceridaemia [21,32] is unclear.
The current study, in contrast, failed to detect any changes in
a wide range of inflammatory and oxidative markers, where
the nutritional challenge was provided as a healthy test meal.
There were two exceptions, however. First, although
adiponectin declined following the test meal, as previously
noted [31], this acute inflammatory response was indepen-
Table 5 Glycaemic and insulinaemic response to the standard test meal at baseline and following dietary intervention
Habitual diet Standard dietary advice Oat-enriched diet sed Pdiet
‡
Incremental area under the curve (AUCi)
glycaemia (mmol/l 9 180 min)
492.7* 589.1† 585.2† 35.9 0.022
Total area under the curve (AUCt)
glycaemia (mmol/l 9 180 min)
1867.7* 2071.7† 2031.1† 67.4 0.012
Incremental area under the curve (AUCi)
insulinaemia (mmol/l 9 180 min)
9882.5 10352.9 10372.7 523.1 0.595
Total area under the curve (AUCt)
insulinaemia (mmol/l 9 180 min)
11853.2 12326.5 12307.9 548.3 0.653
Insulin secretion in response to glycaemic
stimulus (mU/mmol)
26.8 24.7 23.6 1.88 0.243
Values are means. Values within the same row with different symbols (*, †) are different (P < 0.05).
‡Pdiet, comparison between dietary phases.
Table 6 Means of postprandial values for inflammation and oxidative stress marker responses to the test meal at baseline and after dietary
intervention
Habitual diet Standard dietary advice Oat-enriched diet sed P
C-reactive protein (lg/l)* 2.33 (1.95–2.80) 1.93 (1.61–2.31) 2.20 (1.84–2.63) 0.35 0.420
Interleukin 18 (lg/l) (n = 18) 362.4 440.9 380.4 20.61 < 0.001
Adiponectin (lg/l) 4.80 5.01 4.85 0.14 0.452
Thiobarbituric acid reactive
substances (lM)
4.0 4.42 4.18 0.26 0.264
Oxygen radical antioxidant
capacity (lM TE)
26.7 26.7 27.3 0.86 0.473
Isoprostane/creatinine* 91.22 (85.53–97.28) 101.79 (95.44–108.55) 95.95 (89.96–102.32) 4.45 0.078
Values are means.
*For C-reactive protein and isoprostane/creatinine, analyses are on log-transformed data. Presented are the back-transformed means with
their corresponding back-transformed 95% confidence interval in parentheses.
TE, Trolox-Equivalent.
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dent of the chronic dietary intervention. Second, in those
subjects with detectable concentrations of the pro-inflamma-
tory cytokine, IL-18, the postprandial values were lower for
both the habitual and oat-enriched diet compared with
standard dietary advice. The reason for the increase in
response to standard dietary advice is unclear and needs
further investigation. It is reassuring that the test meal used
did not lead to a measurable inflammatory response, in
contrast with the artificial high-fat and carbohydrate loads
used in earlier studies [19–21].
Conclusion
This study has shown no significant differences in measure-
ments of glycaemic control or reduction in postprandial
hyperglycaemia following intervention with the oat-enriched
diet. A small beneficial effect of oats on plasma lipid profiles
was observed and this may have implications for reducing
cardiovascular risk profiles. Oats are an easily identified
dietary ingredient and so may help people with Type 2
diabetes maintain a low glycaemic index and glycaemic load
diet. This would be achieved at no worsening of glycaemic
control compared with standard dietary advice and perhaps
also with some minor benefits.
Consumption of a relatively healthy test meal produced
smaller inflammatory responses than reported using either
artificially high-fat or carbohydrate loads [20,21]. Overall,
the results reinforce the importance of adhering to healthy
eating advice in Type 2 diabetes in terms of reducing
systemic levels of inflammation and oxidative stress, and
therefore cardiovascular risk.
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